Home > industry > manufacturing > Sanofi introduces India’s first indigenous insulin pen

Mumbai: Sanofi India Ltd, a unit of French drug maker Sanofi SA, introduced the country’s first locally manufactured insulin pen in the domestic market on Tuesday.

The device, branded AllStar, is a reusable insulin pen developed especially for Indian patients by Sanofi’s medical device development team in Frankfurt.

Priced at Rs650 apiece in India, about half that of similar imports, Sanofi’s new device will also be sold overseas.

The product is the outcome of a three-year research project. India, home to the second-largest diabetic population in the in the world, has about 64 million patients. The pen is manufactured in Gujarat.

“This product heralds a new era of indigenous device manufacturing for Sanofi India, which we hope to utilize for other devices in future," said Shailesh Ayyangar, managing director, Sanofi India and vice president, South Asia.

Subscribe to newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Click here to read the Mint ePaper Livemint.com is now on Telegram. Join Livemint channel in your Telegram and stay updated

My Reads Logout